Dimetapp wasn’t entirely discontinued, but the original formula most people remember was pulled from shelves in the early 2000s after one of its key ingredients was linked to a serious risk of bleeding in the brain. The product has since been reformulated and still exists in a different version, but the grape-flavored cold medicine many parents grew up with is not the same product sold today.
The Ingredient That Triggered the Change
The original Dimetapp contained phenylpropanolamine (PPA), a decongestant widely used in cold medicines and diet pills throughout the 1980s and 1990s. In 2000, the FDA issued a public health advisory after researchers at Yale University School of Medicine found an association between PPA and hemorrhagic stroke, a type of bleeding in the brain.
The Yale study, known as the Hemorrhagic Stroke Project, found that the increased risk appeared in women using PPA for either nasal decongestion or weight control, particularly in the first three days after starting the medication. Men were considered potentially at risk as well. An FDA advisory committee reviewed the data and concluded that PPA could not be considered safe for continued use. The FDA’s position was blunt: even though the absolute risk of hemorrhagic stroke was low, the conditions PPA treated (stuffy noses, mild congestion) didn’t justify any increased risk of such a serious event.
Manufacturers pulled PPA from their products. For Dimetapp, this meant reformulating with pseudoephedrine as the replacement decongestant, paired with brompheniramine (an antihistamine). This reformulated version is what eventually returned to store shelves, but it was a meaningfully different product from the one people remembered.
Pediatric Safety Concerns Added More Restrictions
A second wave of changes hit Dimetapp and similar children’s cold medicines starting in 2007. Pediatric experts had been concerned for years about the potential for serious side effects from over-the-counter cough and cold products in young children. In March 2007, a group of these experts formally petitioned the FDA to recommend against using such medications in children under six.
The cumulative evidence of harm was significant enough that many pharmaceutical manufacturers didn’t wait for the FDA to act. Members of the Consumer Healthcare Products Association voluntarily pulled infant and toddler cough and cold products from the market during the FDA’s review process. The FDA ultimately warned that children under two should not be given any cough or cold product containing a decongestant or antihistamine, citing the potential for serious and life-threatening side effects. Manufacturers then voluntarily relabeled their remaining products to read “do not use in children under 4 years of age.”
For a brand like Dimetapp, which had built its identity around being a go-to children’s cold medicine, these restrictions fundamentally changed how the product could be marketed and sold. The infant formulations disappeared entirely, and the remaining products carried new age warnings that hadn’t existed before.
What Dimetapp Looks Like Today
Current Dimetapp products contain brompheniramine (1 mg per teaspoon) and pseudoephedrine (15 mg per teaspoon). These are the same general categories of drugs as the original, an antihistamine and a decongestant, but with the safer pseudoephedrine replacing the now-banned PPA. The products are labeled for children four and older, and they’re no longer available in the infant formulations that once lined pharmacy shelves.
The brand has also changed ownership over the years, passing through several pharmaceutical companies. Combined with the formula changes and tighter age restrictions, the Dimetapp on shelves today shares little more than a name and a grape flavor with the version from the 1990s.
Why Some People Think It’s Fully Discontinued
The confusion is understandable. The original formula was removed. Infant versions were pulled. The brand changed hands. And depending on where you shop, certain Dimetapp products can be hard to find due to shifting retail availability and the fact that pseudoephedrine products are sometimes kept behind the pharmacy counter. If you go looking for the specific Dimetapp you or your parents used decades ago, it genuinely doesn’t exist anymore. What remains is a reformulated product under the same brand name, sold with significantly more restrictions than the original ever had.